CEFOTAXIME DISPOSITION PHARMACOKINETICS DURING PERITONEAL-DIALYSIS

被引:1
|
作者
OVERGAARD, S
LOKKEGAARD, N
SCRODER, S
FUGLEBERG, S
NIELSENKUDSK, F
机构
[1] HVIDOVRE HOSP,DEPT MED MICROBIOL,DK-2650 HVIDOVRE,DENMARK
[2] AARHUS UNIV,INST PHARMACOL,DK-8000 AARHUS C,DENMARK
来源
PHARMACOLOGY & TOXICOLOGY | 1987年 / 60卷 / 05期
关键词
D O I
10.1111/j.1600-0773.1987.tb01518.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:321 / 324
页数:4
相关论文
共 50 条
  • [1] DISPOSITION OF CEFOTAXIME AND DESACETYL CEFOTAXIME DURING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    HEIM, KL
    HALSTENSON, CE
    COMTY, CM
    AFFRIME, MB
    MATZKE, GR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (01) : 15 - 19
  • [2] PHARMACOKINETICS OF CEFOTAXIME DURING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    HEIM, K
    HALSTENSON, C
    COMTY, C
    AFFRIME, M
    MATZKE, G
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (06): : 504 - 504
  • [3] CEFOTAXIME(C) PHARMACOKINETICS DURING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD)
    ALEXANDER, D
    GAMBERTOGLIO, J
    BARRIERE, S
    WARNOCK, D
    SCHOENFELD, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (02) : 225 - 225
  • [4] CEFOXITIN DISPOSITION DURING PERITONEAL-DIALYSIS
    GREAVES, WL
    KREEFT, JH
    OGILVIE, RI
    RICHARDS, GK
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (02) : 253 - 255
  • [5] PHARMACOKINETICS OF INTRAVENOUS AND INTRAPERITONEAL CEFOTAXIME IN CHRONIC AMBULATORY PERITONEAL-DIALYSIS
    ALBIN, HC
    DEMOTESMAINARD, FM
    BOUCHET, JL
    VINCON, GA
    MARTINDUPONT, C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (03) : 285 - 289
  • [6] THIAMPHENICOL PHARMACOKINETICS DURING PERITONEAL-DIALYSIS
    FURMAN, KI
    LANDLESS, R
    KILROESMITH, TA
    KOORNHOF, HJ
    ROBINSON, RG
    SOUTH AFRICAN MEDICAL JOURNAL, 1976, 50 (07): : 220 - 220
  • [7] CEFTRIAXONE PHARMACOKINETICS DURING PERITONEAL-DIALYSIS
    KOUP, JR
    KELLER, E
    NEUMANN, H
    STOECKEL, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (03) : 303 - 307
  • [8] PHARMACOKINETICS OF CEFOTAXIME IN PATIENTS UNDERGOING HEMODIALYSIS AND CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    HASEGAWA, H
    IMADA, A
    HORIUCHI, A
    NISHII, Y
    FUKUSHIMA, M
    KUROKAWA, E
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 : 135 - 142
  • [9] CEFOTAXIME AND METABOLITE DISPOSITION IN 2 PEDIATRIC CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS PATIENTS
    PAAP, CM
    NAHATA, MC
    MENTSER, MA
    MAHAN, JD
    PURI, SK
    HUBBARD, JA
    ANNALS OF PHARMACOTHERAPY, 1992, 26 (03) : 341 - 343
  • [10] TEICOPLANIN PHARMACOKINETICS AND BIOAVAILABILITY DURING PERITONEAL-DIALYSIS
    BROUARD, RJ
    KAPUSNIK, JE
    GAMBERTOGLIO, JG
    SCHOENFELD, PY
    SACHDEVA, M
    FREEL, K
    TOZER, TN
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (06) : 674 - 681